The latest news from the CML Advocates Network
WE ARE HIRING!
We are seeking a Chief Executive Officer (CEO) for the CML Advocates Network. There is a unique...
Our contribution to VII Simposio anual GELMC
Dear members & friends of the CML Advocates Network, We are thrilled to share with you our...
WEBINAR: Latest advances in the treatment of chronic myeloid leukemia (CML) – What does this mean for patients?
On Tuesday, 28th March, join us for our educational webinar to hear the latest updates on how CML...
ASH 2022 – CML Advocates Network conference report
The 64th ASH Annual Meeting and Exposition took place from the 10th to the 13th of December, 2022...
CML Horizons 2022 Hybrid Conference Highlights
CML Horizons 2022 started off on 28th October. More than 100 participants from more than 40...
World CML Day 2022
WORLD CML DAY 2022 “United in community and purpose. Towards a cure for CML.” Patient groups from...
CML Life is joining the network!
At the CML Advocates Network, we strive to bring the best resources to CML patient advocates and...
Free CML Education Webcast
Our friends from The Leukemia & Lymphoma Society are organising free CML Education...
CML Horizons 2022 – Registration is now open
Registration info – Preliminary Program – Conference fee – Scholarship Application – Call for...
SAVE THE DATE: CML Horizons 2022
Date: 28 - 30 October 2022 Location: Marrakesh, Morocco Dear members & friends of CML...
20 years of CML patient advocacy for patient access
Access to life-saving therapies is a global responsibility, not a luxury good in countries of the...
ATTENTION: Caregivers &/or supporters of a patient with CML, AML, ALL, or CLL
Do you have somebody close to you who is diagnosed with leukemia? Be part of a global initiative...
New “Know Your CML” App just launched
"Know your CML" is a new mobile app developed by CML Advocates Network. It offers a range of...
Calling CML patients living in Ukraine
CML Advocates Network stands in solidarity with the CML patients in Ukraine. We call on the...
CML Advocates Network statement supporting fellow members and patients in Ukraine.
The CML Advocates Network is an active network specifically for leaders of Chronic Myeloid...
ASH 2021 CML Conference Report
The 63rd ASH Annual Meeting and Exposition organised by the American Society of Hematology was...
EBMT 48th Annual Meeting and Patient, Family and Donor Day
The European Society for Blood and Marrow Transplantation is a collaborative peer network of...
CML Advocates Network Steering Committee 2021
We are excited to formally welcome and introduce the three new members of the CML Advocates...
CML Horizons 2021 Virtual Conference Information
CML Horizons 2020: Learn. Share. Grow.22 – 24 October 2021, Virtual Conference CML Advocates...
ASH 2021 Annual Meeting
The 63rd ASH Annual Meeting and Exposition organised by the American Society of Hematology will be...
CML Advocates Network participating at EHA-SWG 2018 Meeting
The European Hematology Association held the “EHA-SWG Scientific Meeting on Integrated Diagnosis...
CML Advocates Network stands in solidarity with the CML patients in Ukraine.
We call on the international community to address the basic human needs and solve disruptions in...
Apply for an EHA 2022 Fellowship until 17th April
EHA 22 lowThe European Hematology Association (EHA) has already opened the Fellowship Application...
CML Advocates Network co-founders receive the 2022 iCMLf Prize
During the month of March 2022, the International CML Foundation announced the iCMLf Prizes for...
EBMT 48th Annual Meeting and Patient, Family and Donor Day
The European Society for Blood and Marrow Transplantation is a collaborative peer network of...
CML Advocates Network statement supporting fellow members and patients in Ukraine.
The CML Advocates Network is an active network specifically for leaders of Chronic Myeloid...
CML Advocates Network Steering Committee 2021
We are excited to formally welcome and introduce the three new members of the CML Advocates...
ELN Recommendations 2020
The therapeutic landscape of CML has profoundly changed over the past 7 years so the European...
Welcome, Fundación Bekämpa, Ecuador!
We hereby proudly welcome a new member organisation in the CML Advocates Network: Fundación...
How Big Data and large data sets are helping to ask and answer previously unknown questions and answers in research on hematological diseases.
Big Data – the term has been a topic of controversial debate for several years. Why, despite all...
ASH 2020 CML Conference Report
The 62nd ASH Annual Meeting and Exposition organised by the American Society of Hematology was...
Our CMLCAB Abstract published in the OJRD Supplement
Orphanet Journal of Rare Diseases (OJRD), which is the official journal of Orphanet, the portal...
CML Atlas East Europe
CML Atlas East Europe is the final product of East Europe and West Asia regional project run by...
CML Advocates Network regional project: CML LATAM
The Latin American - CML Advocates Network region is currently developing an amazing advocacy...
CML Horizons 2020 Virtual – Call for Posters
Call for posters This year your posters will be displayed virtually and within our conference...
World CML Day 2020: Today, together, more than ever. For a life without CML
Every 22nd September, the CML Advocates Network leads the World CML Day global awareness...
EHA25 VIRTUAL: 25th EHA Annual Congress: “Unfolding the future!”
Just a week left until the European Hematology Association's annual congress starts as a virtual...
Results of the TFR for CML patients’ study published in Leukemia
Bern, Switzerland, 28th May 2020. “The psychological well-being of CML patients should be a...
CML and COVID-19: New Website section on cmladvocates.net
The CML Advocates Network is closely monitoring the current COVID-19 outbreak worldwide. We are...
Coronavirus disease and CML patients
The novel Coronavirus and the COVID-19 Disease Information for Chronic Phase Chronic Myeloid...
Update on stopping CML treatment: Report from the American Society of Hematology Congress 2019
Achieving therapy-free remission (TFR) continues to be amongst the most discussed topics in CML at...
Summary of the CML educational session from ASH 2019
Patients, borders, money, and mission: A global perspective of chronic myeloid leukemia - Summary...
New drugs for CML in clinical trials: ASH 2019
This summary will cover a few of the important topics regarding CML that were presented at ASH...
The CML Clinical Trials data-base now lists 54 studies worldwide
Our clinical trials registry currently lists 54 studies: 32 CML studies actively recruiting...
ASH 2019 in Orlando, USA: CML patient advocates information
Just a few days left until the 61st ASH Annual Meeting and Exposition opens its doors on 7th until...
Welcome to EHA 2019 in Amsterdam, The Netherlands
From June 13-16, 2019, the European Hematology Association holds the 24th EHA annual congress at...
EHA 2019 Highlights: The CML patient advocates perspective
More than 12,000 hematology professionals from around the world met together in Amsterdam, The...
CML Advocates Network appoints Denis Costello as its first ever Executive Director
We’re proud to announce that Denis Costello has recently been appointed as the first Executive...
ASH report on news about generic imatinib
When generic imatinib was introduced between 2013 and 2016 when the Glivec patent expired, generic...
Food effects on Nilotinib: Presentation of the NIFO Study at ASH 2018
Every medicine has different characteristics how the body converts the tablet or capsule into the...
ASH 2018: Asciminib (ABL001) early-phase data of CML patients with T315I mutation
With five approved tyrosine kinase inhibitors (TKIs) and none of them being curative, one may...
European Society of Medical Oncology Congress, Barcelona, 2019
From 27th September to 1st October, the European Society for Medical Oncology Congress...
Today is World CML Day 2019. Play and Learn, Share, Grow with us!
On the World CML Day 2019, the CML Advocates Network is launching an online QUIZ aimed at...
World CML Day 2019 events are starting worldwide!
Today, together, for a CML free world... ... is the motto for this year´s World CML Day campaign,...
World CML Day 2019
"Today, together, for a CML free world." Every year in 22nd September the CML global...
Family Meeting of the German Parents’ Organisation for Children with CML
From 31.05.-02.06.2019 the members of the Parents' Organisation for Children with CML e.V. met in...
CML Horizons 2019 – Presentations, photo gallery and videos now available!
CML Advocacy: Learn. Share. Grow. 17 - 19 May 2019, Lisbon, Portugal The 17th International CML...
€ 20,000 donated to the CML Advocates Network during the EHA 2019 Congress!
The World CML Day CML results from a transformation of a stem cell caused in about 95% of Chronic...
Apply for an EHA 2019 Fellowship until 9th April
The European Hematology Association (EHA) has already opened the Fellowship Application and...
CML Advocates Network with the Rare Disease Day 2019
Chronic Myeloid Leukemia is a Rare Disease What a Rare Disease is? According to the European...
UPDATE: Falsified Iclusig traded globally, discovered in Malaysia (new), Turkey, Switzerland, Argentina and Internet sales with UK/Ireland product batch numbers PR072875 (45mg) and 25A19E09 (15mg)
The World Health Organisation (WHO) has issued a medical product alert today that falsified...
Important Notice: Changes to the CML Horizons 2019 Conference
Important Notice: Changes to the CML Horizons 2019 Conference Dear Members & friends of CML...
Falsified Iclusig traded globally, discovered in Turkey, Switzerland, Argentina and Internet sales with UK/Ireland product batch numbers PR072875 (45mg) and 25A19E09 (15mg)
The World Health Organisation (WHO) has issued a medical product alert today that falsified...
Emerging news regarding CML Horizons 2019
Emerging news regarding CML Horizons 2019 Dear members and friends of the CML Advocates Network,...
ASH 2018 CML Oral and Poster sessions
- ASH 2018 - CML Advocates Network Report by Giora Sharf - Every year in the last years I have...
ASH 2018 Report (I): Treating CML during pregnancy
The 60th American Society of Haematology Annual Meeting and Exposition is taking place from 1-4...
ASH 2018 CML Education Session: With great success comes great responsibility
June 2018 was the 20th anniversary of the clinical use of the first Tyrosine Kinase Inhibitor...
Fellowships available to attend the DIA Europe 2019 Conference
DIA Europe 2019 is an annual conference organized by the global association DIA that connects life...
Be a part of the Patient Advocacy Program for the 13th Annual Patient, Family and Donor Day
The 45th EBMT (European Society for Blood and Marrow Transplantation) Congress will be held in...
RCE-ESO-ESMO training course for rare cancer patient advocates: Travel grants available
Are you are Patient Advocate for Rare Cancers? If so, you need to know about the Training Course...
Report from the first European Hematology Community Advisory Board (Hem-CAB) on 18 June 2018 in Stockholm, Sweden
The European hematology patient community held its first hematology community advisory board...
World CML Day 2018
"Today, Together. Improving access." “We see people dying of CML even though it's a...
TFR 4 CML patients survey
The TFR for CML patients survey is now closed! The CML Advocates Network launched the online...
EHA 2018 in Stockholm, Sweden: Patient Advocacy Programme
Just two weeks left until the European Hematology Association's annual congress starts in...
CML Horizons 2018 – Learn. Share. Grow: Presentations, Photo Gallery and Web streams now available!
CML Advocacy: Learn. Share. Grow. 4 - 6 May 2018, Warsaw, Poland During the annual CML Horizons...
Webinar: Getting the most out of EHA 2018
The European Hematology Association's annual congress will start in Stockholm, Sweden, this week...
CML Advocates Network with the Rare Disease Day 2018
Chronic Myeloid Leukemia is a Rare Disease What is a Rare Disease? The actual prevalence of rare...
Free EHA congress registrations for CML patient organisations representatives: Deadline 27 February 2018!
Again this year, the European Hematology Association (EHA) is providing around 50 free congress...
ASH 2017- personal report, impressions and summary
- Written by Sharf Giora, CML Advocates Network - ASH 2017 is the 10th ASH conference I am...
The CML Clinical Trials data-base now lists 51 studies worldwide
The CML Advocates Network inofficial registry on clinical trials currently lists 51 studies: 28...
ASH 2017 on stopping treatment: Updated data and emerging recommendations for therapy-free remission outside of clinical trials
As in previous years, stopping TKI treatment was a widely discussed topic at this year's ASH...